DHG Pharmaceutical JSC

56
Hold
  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DHG0
VND
100,400.00
100 (0.1%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
DHG Pharmaceutical JSC Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
1,020,429.00
904,484.00
1,159,174.00
1,099,613.00
864,751.00
821,023.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
323,519.00
478,383.00
-703,204.00
-43,045.00
-294,579.00
114,133.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
1,344,670.00
1,474,369.00
420,040.00
1,020,007.00
554,821.00
958,965.00
Cash Flow from Investing Activities
680,028.00
-602,736.00
-359,688.00
-472,451.00
-58,090.00
-380,883.00
Cash Flow from Financing Activities
-1,957,374.00
-902,846.00
-170.00
-550,279.00
-527,864.00
-575,379.00
Net Cash Inflow / Outflow
67,038.00
-31,276.00
60,116.00
-2,945.00
-31,088.00
2,726.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
-286.00
-62.00
-65.00
-222.00
45.00
23.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in VND Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of DHG Pharmaceutical JSC
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Profit Before Tax
1020429.580034
446247.738093
5,74,182.00
128.67%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
323519.957778
-378113.779785
7,01,632.00
185.56%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
1344670.054447
73441.552898
12,71,229.00
1730.94%
Cash Flow from Investing Activities
680028.89991
-95854.054491
7,75,882.00
809.44%
Cash Flow from Financing Activities
-1957374.626414
49653.073103
-20,07,027.00
-4042.10%
Net Cash Inflow / Outflow
67038.117384
27209.909578
39,829.00
146.37%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
-286.210559
-30.661932
-256.00
-833.44%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -8.80% vs 251.01% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
13,44,670.05
14,74,369.20
-8.80%